Videos
Breaking Updates in CAR-T
ASH: MM Takeaway

Mohamad and Saad's definitive guide to multiple myeloma at ASH 2018
Disease Channels

Explore our video content, from lymphomas and leukemias, to MDS, MPNs, and rarer hematological diseases such as Waldenström’s and PNH
Educational Features

Current issues in hemonc, and the latest technologies and therapies are explored by featured international experts
Podcasts

Listen to the latest HemOnc news from international experts, new podcasts monthly
Recent Highlights
Lymphoma
Jithma Prasad Abeykoon
Real world ibrutinib efficacy for Waldenström’s macroglobulinemia
Claire Roddie
Acute Lymphoblastic Leukemia
Claire Roddie
Clinical data for CD19-directed CAR T-cell products in ALL
Acute Myeloid Leukemia
John Byrd
Long-term follow-up of acalabrutinib in CLL
Graham Collins
Acute Lymphoblastic Leukemia
Graham Collins
The roll-out of CAR T-cell therapy in the UK
Diseases
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Acute Promyelocytic Leukemia
Amyloidosis
Anemia
Aplastic Anemia
B-Cell Lymphoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
CNS Lymphoma
Coagulation Disorders
Cutaneous T-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Essential Thrombocythemia
Follicular Lymphoma
Gaucher Disease
General
HIV-Associated Lymphoma
Hodgkin Lymphoma
Leukemia
Leukemia
Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Myelofibrosis
Myeloproliferative Neoplasms
NK/T-cell Lymphoma
Non-Hodgkin Lymphoma
Paroxysmal Nocturnal Hemoglobinuria
Peripheral T-Cell Lymphoma
Polycythemia Vera
Primary Hemophagocytic Lymphohistiocytosis
Sickle Cell Disease
Smoldering Myeloma
Systemic Mastocytosis
T-Cell Lymphoma
T-Lymphocytic Leukemia
Thalassemia
Transfusion-Dependent Anemia
Viral Lymphoma
Von Willebrand Disease
Waldenström’s Macroglobulinemia
View more content
Trials
Medicines
Conferences
Features
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals